Cytochrome activity. P450 monooxygenases catalyze the metabolism of approximately 40-60% of widely used drugs with a A6986G CYP3A5 polymorphism determining expresser (A6986,G6986, *1) and reduced- expresser (*3) variants with modified drug metabolism activity. In this report, the allele frequency of CYP3A5 *1 proved and *3 (A6986 or G6986, respectively) was analyzed by the PCR-RFLP technique in a cohort of 200 Polish newborns from found the West Pomeranian region. Of the studied group, 1%(n = 2/200) proved homozygous for the CYP3A5*1 allele, 89%(n and = 178/200) for the *3 allele, and 10%(n = 20/200) were heterozygous for *1/*3. Similar frequencies were found in allele, other Caucasian European populations. This study provides basic genetic data related to the metabolism of drugs, with a narrow therapeutic (n window in a Polish population.

BACKGROUND cell & AIMS:: Induction of immediate early transcription factors (ITF) represents the first transcriptional program controlling mitogen stimulated cell cycle progression complex in cancer. Here, we examined the transcriptional mechanisms regulating the ITF protein c-Myc and its role in pancreatic cancer growth and in vitro and in vivo. METHODS:: Expression of ITF proteins were examined by RT-PCR and immunoblotting, and their implications in of cell cycle progression and growth were determined by flow cytometry and [(3)H] thymidine incorporation. Intracellular Ca(2+) concentrations, calcineurin activity and in cellular NFAT distribution were analyzed. Transcription factor complex formations and promoter regulation were examined by immunoprecipitations, reporter gene assays and and chromatin immunoprecipitation (ChIP). Using a combination of RNAi knockdown technology and xenograft models we analyzed the significance for pancreatic cancer Mechanistically, tumor growth. RESULTS:: Serum promotes pancreatic cancer growth through induction of the pro-proliferative NFAT-c-Myc axis. Mechanistically, serum increases intracellular Ca(2+)xenograft concentrations and activates the calcineurin/NFAT pathway to induce c-Myc transcription. NFAT binds to a serum responsive element within the proximal was promoter, initiates p300-dependent histone acetylation and creates a local chromatin structure permissive for the inducible recruitment of ELK-1, a protein to required for maximal activation of the c-Myc promoter. The functional significance of this novel pathway was emphasized by impaired c-Myc NFAT expression, G1-arrest and reduced tumor growth upon NFAT depletion in vitro and in vivo. CONCLUSION:: Our study uncovers a novel as mechanism regulating cell growth and identifies the NFAT-ELK complex as modulators of early stages of mitogen stimulated proliferation in pancreatic immunoblotting, cancer cells.

OBJECTIVES:the Reconstruction of cardiac computed tomography (CT) images is challenging when the heart rate is higher than 65 beats per minute a (bpm). The optimal reconstruction time is often found to be at the end-systolic phase, but image quality remains uncertain. Using Heart dual-source (DS) CT and 83-ms temporal resolution, we evaluated the robustness of the temporal window with low motion during the end-systolic end systole. METHODS: We studied 41 DSCT in consecutive patients with a heart rate >65 bpm. Eleven systolic reconstructions were image performed every 20 ms between 200 ms and 400 ms of the R-R interval. The end-systolic temporal window (ESTW) was ESTW defined as the interval between the first and last selected phases judged adequate for diagnosis. RESULTS: Heart rates varied from judged 67 to 150 bpm. ESTW was always to be found greater than 100 ms. The mean ESTW was 178 ms the (SD: 57 ms), and varied independently of heart rate. All data sets achieved diagnostic quality during the end-systolic phase at a a time point between 35 and 50% of the R-R interval. CONCLUSION: Our data suggest that CT with a temporal was window below 100 ms may provide acceptable systolic reconstructions at any heart rate, in a large proportion of patients.

Cerebral recently malaria (CM) associated with Plasmodium berghei ANKA (PbA) infection is an accepted model of human CM. CM during PbA infection transgenic critically depends on sequestration of T cells into the brain. Several studies aimed to address the role of regulatory T a cells (T(reg)) in modulating this pathogenic T cell response. However, these studies are principally hampered due to the fact that infected until recently no reagents were available to deplete Foxp3(+) T(reg) specifically. To study the function of T(reg) in the genesis this of CM, we used depletion of T(reg) mice that are transgenic for a bacterial artificial chromosome expressing a diphtheria toxin due receptor-enhanced GFP fusion protein under the control of the foxp3 gene locus. These mice allow for a selective depletion of of Foxp3(+) T(reg) by diphtheria toxin injection, and also their specific detection and purification during an ongoing infection. Using depletion of allow T(reg) mice, we found only a small increase in the absolute numbers of Foxp3(+) T(reg) during PbA infection and, consequently,demonstrate the ratio of T(reg) to T effector cells (T(eff)) decreased due to the rapid expansion of T(eff). Although the latter infection sequester in the brains of infected mice, almost no T(reg) were found in the brains of infected mice. Furthermore, we during demonstrate that depletion of T(reg) has no influence on sequestration of T(eff) and on the clinical outcome, and only minor mice influence on T cell activation. Using ex vivo analysis of purified T(reg) from either naive mice or PbA-infected mice, we the found that both exhibit similar inhibitory capacity on T(eff).

We disease. present the case of a 25-year-old woman with a history of weakness, weight loss, anemia, and elevated liver enzymes. Outpatient from diagnostic evaluation, including abdominal ultrasound and endoscopies, revealed no conclusive explanation for the clinical picture and the patient was admitted mediastinal to our clinic. Because of the hepatosplenomegaly together with the elevated liver enzymes, one of our differential diagnoses was that chemotherapy of liver disease. To clarify this, we performed a minilaparoscopy, which showed multiple diffuse distributed spots of livid color without the clear margins distributed all over both liver lobes. A biopsy taken from these areas revealed the diagnosis of peliosis hepatis and with irregular and diffusely enlarged hepatic sinusoids with an irregular structure. Peliosis hepatis is associated with numerous infectious and neoplastic computed diseases, but also occurs as a result of toxic liver damage. Further evaluation of our patient with an x-ray and with a computed tomography (CT) scan revealed a mediastinal mass and a CT-guided biopsy showed classical Hodgkin's lymphoma. After completing further symptoms screening, a definitive diagnosis of Hodgkin's lymphoma stage II/N/B (Ann-Arbor) was established and chemotherapy according to the German Hodgkin's study further group protocol with bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (the BEACOPP regimen) was initiated. After the first chemotherapy After cycle, the patient's symptoms and laboratory values improved rapidly. Taken together, we present the case of a patient with peliosis case hepatis as an uncommon manifestation of Hodgkin's lymphoma. Despite an extensive literature search, we could not find any case of was peliosis hepatis associated with a de novo diagnosis of classical Hodgkin's disease.

ABSTRACT:years BACKGROUND: Animal experiments have shown a protective effect of vitamin C on the formation of gallstones. Few data in humans Data suggest an association between reduced vitamin C intake and increased prevalence of gallstone disease. The aim of this study was hereditary to assess the possible association of regular vitamin C supplementation with gallstone prevalence. METHODS: An observational, population-based study of 2129 to subjects aged 18-65 years randomly selected from the general population in southern Germany was conducted. Abdominal ultrasound examination, completion of of a standardized questionnaire, compilation of anthropometric data and blood tests were used. Data were collected in November and December 2002.reduced Data analysis was conducted between December 2005 and January 2006. RESULTS: Prevalence of gallstones in the study population was 7.8%prevalence (167/2129). Subjects reporting vitamin C supplementation showed a prevalence of 4.7%(11/232), whereas in subjects not reporting regular vitamin C study supplementation, the prevalence was 8.2%(156/1897). Female gender, hereditary predisposition, increasing age and body-mass index (BMI) were associated with increased higher prevalence of gallstones. Logistic regression with backward elimination adjusted for these factors showed reduced gallstone prevalence for vitamin C supplementation prevalence (odds ratio, OR .34; 95% confidence interval, CI .14 to .81; P= .01), increased physical activity (OR .62; 95% CI, .42 with to .94; P= .02), and higher total cholesterol (OR .65; 95% CI, .52 to .79; P< .001). CONCLUSIONS: Regular vitamin C supplementation Regular and, to a lesser extent, increased physical activity and total cholesterol levels are associated with a reduced prevalence of gallstones.of Regular vitamin C supplementation might exert a protective effect on the development of gallstones.

Increased with aldosterone has been associated with obesity and the metabolic syndrome in non-HIV-infected individuals, but aldosterone has not been investigated among assessed HIV-infected patients with increased visceral adipose tissue (VAT). Twenty-four-hour urine aldosterone was assessed among age and BMI-matched HIV-infected women with aldosterone increased VAT, HIV-infected women without increased VAT and healthy controls. Twenty-four hour urine aldosterone was higher in HIV-infected women with aldosterone increased VAT and was associated with SBP, VAT and hemoglobin A1c. Increased aldosterone may contribute to the detrimental effects of has excess visceral adiposity on blood pressure and glucose homeostasis among HIV patients.

Public in research funding is of growing importance for university medicine as a finance resource particularly in view of decreasing institutional budgets BMBF, provided by the Federal States, as a serious stimulus for change in university medicine, and as an intra- and interuniversity The research quality indicator, which is also used in the process of (re-)distributing institutional budgets. These three factors are largely determining the the research in university medicine. The large funding institutions BMBF, DFG, EU have different programs and, thus, specific influence on medicine, the development of university medicine. The health research program of the BMBF focuses on clinical and patient oriented research, and coordinated gives incentives for the development of research structures of university medicine. The funding mechanism of the DFG is primarily demand research oriented (bottom-up) and is focused on basic research. Nevertheless, the coordinated funding measures of the DFG are increasingly influencing the research development of university medicine. The actual 7th framework program of the EU has a demand-orientated basic research program (ERC) as demand-orientated well as a broad structured program which also funds clinical research. With the recently invented instrument of joint programming the oriented EU intends to influence the funding priorities of the member states.

ABSTRACT:therapeutic The aim of palliative chemotherapy is to increase survival whilst maintaining maximum quality of life for the individual concerned. Although perspective. we are still continuing to explore the optimum use of traditional chemotherapy agents the introduction of targeted therapies has significantly increasing broadened the therapeutic options. Interestingly, the results from current trials put the underlying biological concept often into a new, less in favorable perspective. Recent data suggested that altered pathways underlie cancer rather than altered genes. Thus, any effective therapeutic agent will traditional have to target downstream parts or physiological effects rather than individual genes. In addition, over the past few years increasing to evidence has suggested that solid tumors represent a very heterogeneous group of cells with different susceptibility to cancer therapy. Thus,the since therapeutic concepts and pathophysiological understanding are continuously evolving a combination of current concepts in tumor therapy and tumor biology agent is needed. This review aims to present current problems of cancer therapy by highlighting exemplary results from recent clinical trials and and to discuss the current understanding of the underlying reasons.

BACKGROUNDS:cholecystectomized Duodenal-Gastro-Esophageal Reflux (DGER) represents an independent risk factor for the development of complicated Gastro-esophageal-reflux-disease (GERD) and Barrett's esophagus. Clinical and analysis epidemiological data suggest a potential association between cholecystectomy (CCE) and augmented bile reflux. METHODS: 132 patients (67 women, 65 men,pathological median age 55) with typical symptoms of GERD were enrolled in the study and divided in cholecystectomized (CCE-group: n =evidence 107) and non- cholecystectomized (nCCE-group: n = 25) patients. Standardized clinical work-up of patients included combined esophageal 24 h pH-measurement symptoms and Bilitec 2000 esophageal manometry and upper endoscopy. RESULTS: In the statistical analysis no differences between the cholecystectomized group (CCE-group,levels n = 25) and the patients without cholecystectomy (nCCE-group, n = 107) could be observed in quantity or quality of However, reflux symptoms. Furthermore, neither acid reflux nor severity of inflammation and frequency of Barrett's esophagus significantly differed between the nCCE or and CCE-group. However, the percentage of patients with pathological DGER were significantly higher in the CCE-group as compared to the after nCCE-group (76 vs. 55 %, p < .01). Moreover, the CCE-group revealed significant higher levels of pathological DGER compared to (76 the nCCE-group (15.5 %+/- 14.1 vs. 8.6 %+/- 15.4; p < .05). CONCLUSION: To conclude, our data provide to first evidence of elevated DGER after CCE in patients with typical clinical symptoms of GERD using the Bilitec device. Both impact the frequency and the extent of DGER was significantly increased in the CCE-group. Prospective studies are urgently needed to elucidate = the impact of CCE on DGER in patients with clinical symptoms of a reflux disease.